| 1 | 1553977-17-5 | Ibrutinib-d5 | Ibrutinib-d5 | C25H24N6O2
| 杂质对照品;对照品-杂质对照品 | |
| 2 | 936563-97-2 | (S)-依鲁替尼 | (S)-Ibrutinib | C25H24N6O2
| 依鲁替尼;杂质对照品;对照品-杂质对照品 | |
| 3 | 936563-87-0 | PCI-32765 (Racemate) | PCI-32765 (Racemate) | C25H24N6O2
| 细胞生物学试剂 | |
| 4 | 865759-10-0 | Alogliptin Related Compound 26 | Alogliptin Related Compound 26 | C25H24N6O2
| 杂质对照品;阿格列汀杂质;对照品-杂质对照品 | |
| 5 | | N-(2-METHOXYPHENYL)-4-(8-PYRIMIDIN-5-YLQUINOLIN-2-YL)PIPERAZINE-1-CARBOXAMIDE | N-(2-METHOXYPHENYL)-4-(8-PYRIMIDIN-5-YLQUINOLIN-2-YL)PIPERAZINE-1-CARBOXAMIDE | C25H24N6O2
| | |
| 6 | 72152-87-5 | 3-[[2-(Acetyloxy)ethyl][4-[[4-(phenylazo)phenyl]azo]phenyl]amino]propanenitrile | 3-[[2-(Acetyloxy)ethyl][4-[[4-(phenylazo)phenyl]azo]phenyl]amino]propanenitrile | C25H24N6O2
| | |
| 7 | | (6-[1-(4-METHOXY-PHENYL)-1H-PYRAZOL-4-YL]-PYRIDIN-3-YL)-(4-PYRIDIN-2-YL-PIPERAZIN-1-YL)-METHANONE | (6-[1-(4-METHOXY-PHENYL)-1H-PYRAZOL-4-YL]-PYRIDIN-3-YL)-(4-PYRIDIN-2-YL-PIPERAZIN-1-YL)-METHANONE | C25H24N6O2
| | |
| 8 | 936563-92-7 | 依鲁替尼杂质11 | 2-Propen-1-one, 1-[4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]-1-piperidinyl]- | C25H24N6O2
| 杂质;依鲁替尼;定制中心 | |
| 9 | 936563-96-1 | 1-[(3R)-3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶基]-2-丙烯-1-酮 | 1-((3r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-2-propen-1-one | C25H24N6O2
| 原料;原料药;中间体;抑制剂;血管生成;化工原料;医药原料;化学试剂;医药中间体;医药原料药 | |